Partnership addresses the unmet need for remyelination therapies for multiple sclerosis and other demyelinating conditions by leveraging generative chemistry design ...
3.1.1. Novus Holdings Limited (‘Novus’ or ‘Offeror’) is a JSE-listed company primarily engaged in printing and packaging operations. It announced a mandatory offer for Mustek Limited at R13.00 per ...
U.S. Food and Drug Administration (FDA) allows advancement of RAP-219 into registrational trials for focal onset seizures (FOS); accelerated initiation of Phase 3 program expected in the second quarte ...
Slomp Filho, M. (2026) Copyright in Generative Artificial Intelligence. Beijing Law Review, 17, 1-10. doi: ...
Background Ebstein’s anomaly (EA) exhibits significant anatomical and clinical heterogeneity, warranting a systematic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback